RESPONSE GENETICS INC Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD; shares in millions, except per-share amounts

	FY2014 12 months to Dec 31, 2014	FY2013 12 months to Dec 31, 2013	FY2012 12 months to Dec 31, 2012	FY2011 12 months to Dec 31, 2011
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Amortization of loan costs and debt discounts
Bad debt expense
Share-based compensation - employees
Loss on sale of property and equipment
Impairment of property and equipment
Restricted stock compensation - consultants
Changes in operating assets and liabilities:
Accounts receivable
Prepaid expenses and other current assets
Accounts payable
Accrued expenses
Accrued royalties
Accrued payroll and related liabilities
Deferred revenue
Net cash used in operating activities

Cash flows from investing activities:
Purchase of property and equipment
Purchase and capitalization of software
Cash paid for purchase of assets
Proceeds from sale of equipment
Net cash used in investing activities
Cash flows from financing activities:
Proceeds from issuance of common stock, net of offering costs
Proceeds from the issuance of debt, net of costs and debt discount of $386,112
Proceeds from line of credit
Proceeds from exercise of stock options
Capital lease payments
Net cash provided by financing activities
Effect of foreign exchange rates on cash and cash equivalents
Net decrease in cash and cash equivalents
Cash and cash equivalents:
Beginning of the year
End of the year
Cash paid during the period for:
Income taxes
Interest
Property and equipment acquired by capital lease

Supplemental disclosure of non-cash financing activities:
Equipment and software acquired under capital leases
Warrants issued with term debt
Assets acquired by issuance of common stock
Reclassification of mezzanine equity to Stockholders’ Equity (Deficit)

Comments